The OAI status implies that the USFDA may put all new approvals from the Halol facility on hold till the outstanding corrective actions are completed.from Moneycontrol Business News https://ift.tt/3artekw
Monday, March 30, 2020
USFDA classifies Sun Pharma#39;s Halol manufacturing site for official action, may put all new approvals on hold
The OAI status implies that the USFDA may put all new approvals from the Halol facility on hold till the outstanding corrective actions are completed.from Moneycontrol Business News https://ift.tt/3artekw
Subscribe to:
Post Comments (Atom)
-
Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology f...
-
The EUA will facilitate broader use of remdesivir to treat hospitalized patients with severe COVID-19 disease, enabling access to remdesivi...
No comments:
Post a Comment